One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 31, Issue 4, Pages 663-671
Publisher
Oxford University Press (OUP)
Online
2015-11-27
DOI
10.1093/ndt/gfv388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation
- (2015) Hideki Ishida et al. TRANSPLANT INTERNATIONAL
- Three-Year Outcomes Following 1420 ABO-Incompatible Living-Donor Kidney Transplants Performed After ABO Antibody Reduction
- (2015) Gerhard Opelz et al. TRANSPLANTATION
- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
- (2014) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption
- (2014) Annelies E. de Weerd et al. TRANSPLANT INTERNATIONAL
- An update on ABO-incompatible kidney transplantation
- (2014) Stefan Zschiedrich et al. TRANSPLANT INTERNATIONAL
- Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation
- (2014) Krista L. Lentine et al. TRANSPLANTATION
- Significance of isoagglutinin titer in ABO-incompatible kidney transplantation
- (2013) Dahae Won et al. JOURNAL OF CLINICAL APHERESIS
- Impact of the Baseline Anti-A/B Antibody Titer on the Clinical Outcome in ABO-Incompatible Kidney Transplantation
- (2013) Byung Ha Chung et al. NEPHRON CLINICAL PRACTICE
- Successful ABO-Incompatible Kidney Transplantation with Antibody Removal and Standard Immunosuppression
- (2011) S. M. Flint et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption
- (2011) Markus Wahrmann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation
- (2011) H. Genberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience
- (2011) A. Habicht et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience
- (2010) Hiroki Shirakawa et al. CLINICAL TRANSPLANTATION
- Impact of Mycophenolate Mofetil on Wound Complications and Lymphoceles after Kidney Transplantation
- (2010) Kai Lopau et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis
- (2010) J. Wilpert et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Postoperative Bleeding after AB0-incompatible Living Donor Kidney Transplantation
- (2010) F.C. Renner et al. TRANSPLANTATION PROCEEDINGS
- ABO-Incompatible Kidney Transplantation Using Antigen-Specific Immunoadsorption and Rituximab: A 3-Year Follow-up
- (2009) Helena Genberg et al. TRANSPLANTATION
- ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation
- (2009) Robert A. Montgomery et al. TRANSPLANTATION
- A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation
- (2009) Gunnar Tydén et al. TRANSPLANTATION
- A Randomized, Prospective Trial of Rituximab for Acute Rejection in Pediatric Renal Transplantation
- (2008) V. Zarkhin et al. AMERICAN JOURNAL OF TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started